Clinical Trials in Illinois

Showing 6881-6900 of 14,943 trials

Clot Dissolving Treatment for Blood Clots in the Lungs

NCT00680628

The purpose of this study is to determine if tenecteplase plus enoxaparin is safe and effective in the treatment of patients with severe submassive pulmonary embolism.

Pulmonary Embolism

Wake Forest University Health Sciences83 participantsStarted May 2008

Sacramento, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +4 more locations

COMPLETEDPhase 3125 miles

Open-Label Safety Study of AXS-05 in Subjects With Depression

NCT04039022

An open-label, long-term, safety study of AXS-05 in patients with major depressive disorder (MDD), including treatment resistant depression.

Major Depressive DisorderTreatment Resistant DepressionDepression

Axsome Therapeutics, Inc.876 participantsStarted Jul 2019

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Bellflower, California, United States +48 more locations

Clot Dissolving Treatment for Blood Clots in the Lungs

Open-Label Safety Study of AXS-05 in Subjects With Depression

Find Trials by Condition in Illinois

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Trial of Roflumilast in Asthma Management (TRIM)

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Efficacy of Erenumab on Functional Impact of Migraine

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)